Evidence map›Paper›PMID 36124847›Full record

ArticleThe Journal of clinical endocrinology and metabolism2022

The SELFI Study: Iodine Excess and Thyroid Dysfunction in Women Undergoing Oil-Soluble Contrast Hysterosalpingography.

Divya M Mathews, Jane M Peart, Robert G Sim, Neil P Johnson, Susannah O'Sullivan, José G B Derraik, Paul L Hofman

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Divya M MathewsLiggins Institute, University of Auckland, Auckland 1142, New Zealand.ORCID 0000-0002-5163-1588
Jane M PeartDepartment of Radiology, Auckland Radiology Group, Auckland 1050, New Zealand.
Robert G SimDepartment of Radiology, Auckland Radiology Group, Auckland 1050, New Zealand.
Neil P JohnsonDepartment of Obstetrics and Gynecology, Robinson Research Institute, University of Adelaide, Adelaide, South Australia 5006, Australia.
Susannah O'SullivanDepartment of Endocrinology, Greenlane Clinical Centre, Auckland District Health Board, Auckland 1051, New Zealand.
José G B DerraikLiggins Institute, University of Auckland, Auckland 1142, New Zealand.
Paul L HofmanLiggins Institute, University of Auckland, Auckland 1142, New Zealand.
University of Auckland · NZPacific Radiology (New Zealand) · NZGreenlane Clinical Centre · NZThe University of Adelaide · AU

Funding

Guerbet Pharmaceuticals
6 · The paper itself

Abstract

contextHysterosalpingography (HSG) with oil-soluble contrast medium (OSCM) improves pregnancy rates. However, OSCM has high iodine content and long half-life, leading to potential iodine excess.

objectiveThis work aimed to determine the pattern of iodine excess after OSCM HSG and the effect on thyroid function.

methodsA prospective cohort study was conducted of 196 consecutive consenting eligible women without overt hypothyroidism or hyperthyroidism. All completed the study with compliance greater than 95%. Participants underwent OSCM HSG (Auckland, 2019-2021) with serial monitoring of thyrotropin (TSH), free thyroxine (FT4), and urine iodine concentration (UIC) for 24 weeks. The main outcome measure was the development of subclinical hypothyroidism (SCH), defined as a nonpregnant TSH greater than 4 mIU/L with normal FT4 (11-22 pmol/L) in those with normal baseline thyroid function.

resultsIodine excess (UIC ≥ 300 μg/L) was almost universal (98%) with UIC peaking usually by 4 weeks. There was marked iodine excess, with 90% and 17% of participants having UIC greater than or equal to 1000 μg/L and greater than 10 000 μg/L, respectively. Iodine excess was prolonged with 67% having a UIC greater than or equal to 1000 μg/L for at least 3 months. SCH developed in 38%; the majority (96%) were mild (TSH 4-10 mIU/L) and most developed SCH by week 4 (75%). Three participants met the current treatment guidelines (TSH > 10 mIU/L). Thyroxine treatment of mild SCH tended to improve pregnancy success (P = .063). Hyperthyroidism (TSH < 0.3 mIU/L) occurred in 9 participants (5%).

conclusionOSCM HSG resulted in marked and prolonged iodine excess. SCH occurred frequently with late-onset hyperthyroidism occasionally. Regular thyroid function tests are required for 6 months following this procedure.

Indexed as

HyperthyroidismHypothyroidismIodineThyroid DiseasesFemaleHumansHysterosalpingographyIodidesPregnancyProspective StudiesThyrotropinThyroxineIodidesIodineThyrotropinThyroxinehysterosalpingographyiodineoil-soluble contrastpregnancythyroid

Identifiers

PMID36124847
PMCPMC9693785
OpenAlexW4296396782

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.